triptolide has been researched along with Di Guglielmo Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Q; Jin, Y; Lu, Z; Pan, J; Wu, Y | 1 |
1 other study(ies) available for triptolide and Di Guglielmo Disease
Article | Year |
---|---|
Triptolide inhibits Jak2 transcription and induces apoptosis in human myeloproliferative disorder cells bearing Jak2V617F through caspase-3-mediated cleavage of Mcl-1.
Topics: Amino Acid Substitution; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspase Inhibitors; Cell Cycle; Cell Line, Tumor; Cycloheximide; Diterpenes; DNA Primers; Epoxy Compounds; Flow Cytometry; Humans; Janus Kinase 2; Leukemia, Erythroblastic, Acute; Myeloid Cell Leukemia Sequence 1 Protein; Myeloproliferative Disorders; Phenanthrenes; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transcription, Genetic | 2010 |